Publications by authors named "Dieter Scheller"

Claim this Profile
I
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease.
Carlo Wilke, Marcia Cristina Teixeira Dos Santos, Claudia Schulte, Christian Deuschle, Dieter Scheller

Mov Disord· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis.
Marcia Cristina T Dos Santos, Dieter Scheller, Claudia Schulte, Irene R Mesa, Peter Colman

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.
Marcia Cristina T Dos Santos, Miguel Arturo Barreto-Sanz, Bruna Renata S Correia, Rosie Bell, Catherine Widnall, Dieter Scheller

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.
Daniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, Dieter Scheller, Irene Rebollo-Mesa

Front Aging Neurosci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets.
Anne Michel, Jean-Marie Nicolas, Sarah Rose, Michael Jackson, Peter Colman, Dieter K Scheller

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's Inside Out.
Jon Stamford, Dieter Scheller, Peter Jenner

J Parkinsons Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs.
Anne Michel, Patrick Downey, Xavier Van Damme, Catherine De Wolf, Rainer Schwarting, Dieter Scheller

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease.
Anne Michel, Patrick Downey, Jean-Marie Nicolas, Dieter Scheller

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new dopaminergic nigro-olfactory projection.
Günter U Höglinger, Daniel Alvarez-Fischer, Oscar Arias-Carrión, Miriam Djufri, Andrea Windolph, Dieter Scheller

Acta Neuropathol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domain.
Erfan Younesi, Ashutosh Malhotra, Michaela Gündel, Phil Scordis, Alpha Tom Kodamullil, Dieter Scheller

Theor Biol Med Model· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.
Mathieu Bourdenx, Sandra Dovero, Michel Engeln, Simone Bido, Matthieu F Bastide, Dieter Scheller

Acta Neuropathol Commun· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture.
Khaled Radad, Dieter Scheller, Wolf-Dieter Rausch, Heinz Reichmann, Gabrielle Gille

Folia Neuropathol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors.
Martyn Wood, Vanessa Dubois, Dieter Scheller, Michel Gillard

Br J Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture.
Sandra Oster, Khaled Radad, Dieter Scheller, Marlen Hesse, Wladimir Balanzew

Eur J Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms underlying and medical management of L-Dopa-associated motor complications.
Manfred Gerlach, Peter Riederer, Dieter Scheller

J Neural Transm (Vienna)· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.
Dieter Scheller, Christoph Ullmer, Reinhard Berkels, Mirella Gwarek, Hermann Lübbert

Naunyn Schmiedebergs Arch Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements.
Werner J Schmidt, Heike Lebsanft, Manfred Heindl, Manfred Gerlach, Edna Gruenblatt, Dieter K A Scheller

J Neural Transm (Vienna)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat.
Dieter Scheller, Nick Dürmüller, Paul Moser, Roger D Porsolt

Eur J Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease.
Dieter Scheller, Christine Stichel-Gunkel, Hermann Lübbert, Gregory Porras, Paula Ravenscroft

Neurosci Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates.
Sarah Rose, Dieter K A Scheller, Alexander Breidenbach, Lance Smith, Michael Jackson

Behav Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease.
Dieter Scheller, Piu Chan, Qin Li, Tao Wu, Renling Zhang

Exp Neurol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection.
Jan Kehr, Xiao-Jing Hu, Takashi Yoshitake, Dieter Scheller

J Chromatogr B Analyt Technol Biomed Life Sci· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant properties of rotigotine in experimental models of depression.
Valerie Bertaina-Anglade, Christophe Drieu La Rochelle, Dieter K A Scheller

Eur J Pharmacol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectivity in the photodimerization of 6-alkylcoumarins.
Xiuling Yu, Dieter Scheller, Otto Rademacher, Thomas Wolff

J Org Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis